A 32-year-old multigravida at 32 weeks of gestation with known gestational diabetes mellitus (diagnosed at 24 weeks) presents for routine follow-up. She has been on medical nutrition therapy for 6 weeks. Her home blood glucose log shows: fasting 98–102 mg/dL, 2-hour postprandial 155–165 mg/dL. She is compliant with diet and exercise. What is the most appropriate next step in management?
A. Start metformin 500 mg once daily and review in 1 week
B. Start insulin therapy (NPH 10 units at bedtime) and review in 3 days
C. Continue medical nutrition therapy alone and recheck glucose levels in 2 weeks
D. Perform a repeat 75 g OGTT to confirm persistent hyperglycemia
Explanation
Assessment of Glycemic Control Failure
Key Point
After 2 weeks of optimized medical nutrition therapy (MNT), if fasting glucose remains ≥95 mg/dL or 2-hour postprandial ≥120 mg/dL, pharmacotherapy must be initiated. This patient has failed MNT and requires insulin.
Target vs. Actual Glucose Levels
Table
Parameter
Target (mg/dL)
Patient's Value (mg/dL)
Status
Fasting
<95
98–102
Above target
2-hour postprandial
<120
155–165
Significantly above target
High-YieldNEET PG
Persistent hyperglycemia despite adequate MNT (6 weeks) indicates need for pharmacotherapy. Insulin is preferred over metformin in pregnancy because:
Insulin does not cross the placenta
Metformin crosses placenta and long-term fetal safety data are limited
Insulin is the gold standard for GDM pharmacotherapy
Insulin Initiation in GDM
Loading diagram...
Clinical Pearl
NPH (neutral protamine Hagedorn) is preferred for basal insulin in pregnancy because of its long track record of safety. Rapid-acting insulins (lispro, aspart) are added for postprandial control if needed.
Mnemonic: INSULIN in GDM — Insulin is Not crossing placenta, Safe in pregnancy, Unlike metformin, Long-acting (NPH) preferred, Initiated when Nutrition fails
Monitoring After Insulin Initiation
Review glucose logs in 3 days (not 2 weeks) to assess response and titrate dose
